(Q73190576)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Antisense mapping: assessing functional significance of genes and splice variants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

G W Pasternak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y X Pan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Methods in Enzymology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

51-60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

Antisense oligonucleotide strategies in neuropharmacology

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Perspectives in antisense therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

The application of antisense oligonucleotide technology to the brain: some pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Progress in antisense oligonucleotide therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Potent and selective inhibition of gene expression by an antisense heptanucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Antisense strategies in neurobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Molecular biology of opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

An opiate-receptor gene family reunion.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Cloning and characterization of a mouse sigma1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Antisense Oligodeoxynucleotides to the Cloned δ Receptor DOR‐1: Uptake, Stability, and Regulation of Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

G proteins and opioid receptor-mediated signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2914094-1

7 January 2021

10.1016/S0076-6879(99)14094-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10565004%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference